{"url_path":"/sec/prax/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1689548/0001689548-26-000049-index.html","accession_number":"0001689548-26-000049","cik":"0001689548","ticker":"PRAX","issuer_name":"Praxis Precision Medicines, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1689548/0001689548-26-000049-index.html","primary_entity_key":"0001689548","primary_entity_name":"Praxis Precision Medicines, Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNo.\n  Description\n\n[99.1](praxisq12026pr.htm)\n  \n[Press Release, dated](praxisq12026pr.htm)[Ma](praxisq12026pr.htm)[y](praxisq12026pr.htm)[7](praxisq12026pr.htm)[, 2026](praxisq12026pr.htm)\n\n[99.2](praxiscorporatedeckmay_2.htm)\n\n[Praxis Precision Medicines, Inc. May 2026 Corporate Presentation](praxiscorporatedeckmay_2.htm)\n\n104Cover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nPRAXIS PRECISION MEDICINES, INC.\n\nDate: May 7, 2026\nBy: /s/ Marcio Souza\n\n Marcio Souza\n\n Chief Executive Officer"}